Table 1.
Clinico-pathologic features of the Hodgkin lymphoma patients
| Characteristics | Number 81 (%) |
|---|---|
| Age (years) | |
| Mean ± SD | 40.7 ± 15.5 |
| Gender | |
| Male | 51 (63%) |
| Female | 30 (37%) |
| Stage | |
| I | 1 (1.23%) |
| II | 27 (33.3%) |
| III | 39 (48.15%) |
| IV | 14 (17.3%) |
| Histological subtypes | |
| Nodular sclerosis | 45 (55.5%) |
| Mixed cellularity | 33 (40.7%) |
| Lymphocyte-rich | 2 (2.46%) |
| Lymphocyte- depleted | 1 (1.23%) |
| B symptoms | |
| Negative | 59 (72.8%) |
| Positive | 22 (27.1%) |
| Bulky disease | |
| ≥ 10CM | 17 (21%) |
| < 10CM | 64 (79%) |
| International Prognostic Score (IPS) | |
| ≥ 4 (high risk) | 19 (23.4%) |
| < 4 (low risk) | 62 (76.5%) |
| Management | |
| Primary treatment ABVD | 81(100) |
| IFRT | 8 (9.87%) |
| 2nd line | 20 (24.6%) |
| BMT | 1 (1.2%) |
IFRT Involved Field radiotherapy, BMT bone marrow transplantation